Abbott, Alere Antitrust Mediation Ends Without Resolution

Updated on
  • Alere suit claims Abbott is deliberately delaying FTC approval
  • Case reverts to Delaware judge who suggested failed mediation

Efforts to have a mediator resolve antitrust disagreements in Abbott Laboratories’ stalled $5.8 billion takeover of Alere Inc. have failed, Alere said in a regulatory filing Monday.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.